Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL : revenue, balance sheet and financial ratios

SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL is a French company founded 5 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in LA SEYNE-SUR-MER (83500), this company of category PME shows in 2025 a net income negative of -3 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL (SIREN 891698524)
Indicator 2025 2024 2023 2022
Revenue N/C N/C N/C N/C
Net income -3 196 € -3 766 € 16 414 € 26 741 €
EBITDA -968 € -1 507 € -907 € -199 €
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2025, SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL records a net loss of 3 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-968 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-968 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-3 196 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 95%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

95.469%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

49.914%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-73.368

Solvency indicators evolution
SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL

Sector positioning

Debt ratio
95.47 2025
2023
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Average

In 2025, the debt ratio of SPFPL DE PHARMACIENS D'OF... (95.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
49.91% 2025
2023
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Average

In 2025, the financial autonomy of SPFPL DE PHARMACIENS D'OF... (49.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-73.37 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.77 years
Q3: 6.12 years
Excellent -50 pts over 3 years

In 2025, the repayment capacity of SPFPL DE PHARMACIENS D'OF... (-73.37) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 588.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

588.594

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-167.355

Liquidity indicators evolution
SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL

Sector positioning

Liquidity ratio
588.59 2025
2023
2024
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Average

In 2025, the liquidity ratio of SPFPL DE PHARMACIENS D'OF... (588.59) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-167.35x 2025
2023
2024
2025
Q1: -191.54x
Med: -25.42x
Q3: 0.0x
Average

In 2025, the interest coverage of SPFPL DE PHARMACIENS D'OF... (-167.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL in its sector

Comparison with sector Fonds de placement et entités financières similaires

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL

What is the revenue of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL ?

The revenue of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL profitable?

SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL recorded a net loss in 2025.

Where is the headquarters of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL ?

The headquarters of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL is located in LA SEYNE-SUR-MER (83500), in the department Var.

Where to find the tax return of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL ?

The tax return of SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL operate?

SPFPL DE PHARMACIENS D'OFFICINE KAMAL KESSAL operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.